In a study of Li et al. [89], cancer-related CD44-targeting hyaluronic acid (HA) was complexed with NGR to test the effect of the addition of an NGR motif on the tumor uptake of HA (as presented in Table 2). The gene discussed is RTN4R; the disease is neoplasm.